Sameer A Greenall 25th Lorne Cancer Conference 2013

Abstracts this author is presenting:

• Glioblastoma-specific Domain IV mutations in the EGFR are able to covalently dimerise in response to ligand and the small molecule inhibitors gefitinib and erlotinib. — Poster Session 1